The world celebrates a decade of the CRISPR/Cas system, the gene editing technology that unlocked astonishing potential across innovation spaces. But what exactly is CRISPR/Cas? How does it work? What lessons can we learn from the scholarship and tenacity of Dr. Jennifer Doudna and Dr. Emmanuelle Charpentier? Where do we go from here? This article answers these questions, and more.

How will biotechnology affect our everyday lives in the coming years, specifically the world of sports? Could technologies like CRISPR be useful? Is this future “good” or “bad”? Dr. Tiffany Vora explored these questions with a group of executives in Australia.